As of April 2024 Apellis Pharmaceuticals has a market cap of $6.02 Billion. This makes Apellis Pharmaceuticals the world's 2327th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $6.02 B | -15.11% |
2023 | $7.09 B | 24.06% |
2022 | $5.71 B | 24.22% |
2021 | $4.60 B | 6.25% |
2020 | $4.33 B | 121.28% |
2019 | $1.95 B | 163.74% |
2018 | $0.74 B | -32.04% |
2017 | $1.09 B |
On Apr 23rd, 2024 the market cap of Apellis Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.54 B | -90.88% | ๐บ๐ธ USA |